Tanya Farber Senior science reporter

Tanya Farber is the senior science reporter for the Sunday Times and TimesLIVE.

Tanya Farber Senior science reporter
Rare chance for Africa to make its own vaccines, but market must buy

Global summit says procurement agencies must commit to purchasing locally

Tanya Farber Senior science reporter
Covid-19 pandemic at a ‘turning point’: groundbreaking study

Wits University publishes world’s first study on decoupling Omicron from death

Tanya Farber Senior science reporter
Tear down the silos: Cyril shares lessons from WHO vaccine hub

The president says a well-functioning ecosystem that brings partners together is the only way forward

Tanya Farber Senior science reporter
Cape Town’s 300MW solar power plan will be litmus test: mayor Hill-Lewis

The City of Cape Town is the first municipality to open its doors to independent power providers.

Tanya Farber Senior science reporter
J&J pauses vaccine production, but SA stands strong with own clone in the ...

Many countries in developing world will see shortfall, says New York Times

Tanya Farber Senior science reporter
Nearly 300,000 dead from Covid-19 in SA — and the threat is not over

Scientists warn that while the Omicron variant of Covid is milder for most, it can still kill and is adding daily to the total of almost 300,000 ...

Tanya Farber Senior science reporter
Ramaphosa meets head of WHO for talks on Africa's bid to combat Covid-19

President Cyril Ramaphosa welcomed World Health Organisation director-general Tedros Ghebreyesus to his official residence at Genadendal in Cape Town ...

Tanya Farber Senior science reporter
Teen killings lift mirror to our society and we cannot look away

These three stories rocked the country, but now everyone has moved on and the mayhem continues

Tanya Farber Senior science reporter
Investigation reveals how BioNTech undermined SA-based WHO vaccine hub for ...

Documents show how a biotech giant aimed to exploit regulatory framework and shipping-container setup to send vaccines from Africa to Europe.

Tanya Farber Senior science reporter
New jab on the vaccine block: Sinopharm registered by Sahpra

South Africans have become familiar with the Pfizer-BioNTech (known as the Comirnaty vaccine) and Johnson & Johnson vaccines which, to date, are the ...